Thompson Jaye
Greenwich LifeSciences, Inc. · VP Clinical Reg Affairs
Thompson Jaye is listed in filings as VP Clinical Reg Affairs at Greenwich LifeSciences, Inc.. This profile follows SEC Form 4 activity through Dec 27, 2024, including purchase activity. Recent filings connect the profile to Greenwich LifeSciences, Inc. (GLSI). The current snapshot covers public activity from Jul 22, 2024 to Dec 27, 2024. Reported amounts are shown as $16.0K to $11.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $16k1k shares | BuyJul 18, 2024 | $16.00 | $16.32 | |
| $15k1k shares | BuyAug 2, 2024 | $15.15 | $16.32 | |
| $11k800 shares | BuyAug 12, 2024 | $13.85 | $16.32 |